Of Counsel
Practice Areas:
Corporate
Mr. Fabbri has over a decade of experience working with life science companies. Bill works with companies on a number of transactional and contractual matters including business development transactions such as licensing, collaborations and distribution agreements, core industry agreements such as sponsored research, manufacturing, clinical trial and CRO agreements, financings, corporate governance and Board matters and employment and consulting agreements. With his experience both working as in-house and outside counsel, Bill understands how to work with a company’s various teams, including management, directors and scientists, as a business partner, not just as an attorney.
In addition to his association with Furman Gregory Deptula, since 2007 Mr. Fabbri has been the founding member of Fabbri Law, LLC, a law firm focusing exclusively on the life sciences. Prior to Fabbri Law, LLC, Mr. Fabbri served for four years as the General Counsel and a member of the senior management team of GlycoGenesys, Inc., a NASDAQ-listed biopharmaceutical company and six years as a corporate attorney with McDermott, Will & Emery in its Boston office. At GlycoGenesys, he was responsible for all legal functions of the company, including licensing, contracts, financings, public-company reporting, patents and litigation. He structured and closed a number of financings, provided Board guidance, set patent strategy and oversaw outside patent counsel, handled employment matters, and managed litigation counsel. At McDermott, Will & Emery he specialized in securities and corporate matters, including IPOs, acquisitions and public company reporting.
Mr. Fabbri earned his law degree, magna cum laude, from Boston University School of Law in 1996 and his undergraduate degree from Wesleyan University in 1991. He is a member of the Massachusetts Bar, the American Bar Association, the Massachusetts Bar Association, the New England Corporate Counsel Association and is a reviewer for the Massachusetts Technology Transfer Center’s Investigator Award program. He is not admitted in Maine.
